Parsimony, Inc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 51-636 Kamehameha Hwy Apt 124, Kaaawa, HI 96730 Phone: 808-202-6546 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
The Jackson Laboratory announced today that technology investor David Roux and his wife Barbara have gifted $10 million to support research and find cures for genetically based diseases.
NOXXON Pharma today announced the treatment of the first cohort of three chronic lymphocytic leukemia (CLL) patients in a Phase IIa clinical trial of its NOX-A12 anti-CXCL12/SDF-1 (CXC Chemokine Ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer.
Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.
Men who regularly take part in moderate-to-heavy intensity exercise such as jogging, tennis or swimming may be less likely to have a stroke than people who get no exercise or only light exercise, such as walking, golfing, or bowling, according to a study published in the November 24, 2009, print issue of Neurology ®, the medical journal of the American Academy of Neurology.
› Verified 7 days ago